Ozempic is forcing Australia's major private health insurers to rethink their rebates from sust debate Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
⏲ Duration: 1:39 👁 View: 1.4M times ✓ Published: 21-May-2024
Description: Private health insurers have entered the debate over using diabetes drugs for weight loss, with some removing rebates for the medications from their policies. It's left some people struggling with obesity-related health issues caught in the middle.